Feldbaum to Biotech Leaders: Cooperate and Share

Photo: Courtesy of Carl Feldbaum Carl Feldbaum Financiers and biotechnology business leaders suspended their networking for a few minutes at the BIO 2002 annual convention in Toronto as Carl Feldbaum, chairman of the powerful US Biotechnology Industry Organization, urged them to cooperate with their competitors and assist the poor. Feldbaum's 10-point Biotechnology Foreign Policy,1 introduced over a sumptuous lunch, would provide appropriate and affordable vaccines and drugs for developi

Written byPaula Park
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Financiers and biotechnology business leaders suspended their networking for a few minutes at the BIO 2002 annual convention in Toronto as Carl Feldbaum, chairman of the powerful US Biotechnology Industry Organization, urged them to cooperate with their competitors and assist the poor.

Feldbaum's 10-point Biotechnology Foreign Policy,1 introduced over a sumptuous lunch, would provide appropriate and affordable vaccines and drugs for developing countries and ensure the protection of intellectual property while promoting free trade. "Our goal must be to ensure the widest possible dissemination of biotechnology's benefits while respecting the diversity of the world's nations and peoples," Feldbaum said in his plenary address to the annual convention in June. The convention provided companies access to management assistance and financing. "For a model, I looked to President Woodrow Wilson's Fourteen Points, which articulated his international goals after the carnage of World War I."

But it's still early to enroll in a ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies